adenomyosis
Conditions
Interventions
Experimental group:The initial concentration of ropivacaine is set at 0.065%. If analgesia is ineffective, the concentration is increased by 0.005%. If analgesia is effective, the concentration is dec
Sponsors
Suining Central Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1: ASA grade I - III 2: The lesion can be clearly displayed under ultrasound and there are no large blood vessels nearby 3: Patients undergoing high-intensity focused ultrasound surgery 4: 18-65 years old
Exclusion criteria
Exclusion criteria: 1: coagulation disorders 2: skin ulceration or infection in the treatment area. 3: acute pelvic inflammatory disease or acute infection of the reproductive system 4: unable to communicate effectively in the perioperative period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Half effective dose and 95% effective dose of sufentanil combined with ropivacaine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesic effect;Patient satisfaction;Blood pressure, heart rate, pulse, oxygen saturation, etc;modified Bromage score;Adverse reactions (tingling sensation of lower limbs, skin burns, urinary retention, nausea and vomiting, etc.); | — |
Countries
China
Contacts
Public Contactzhang yang
Suining Central Hospital
Outcome results
None listed